VenuGopalBathiniMD
Oncology • Framingham, MAAssistant Professor, Medicine, University Massachusetts Medical School
Dr. Bathini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
571 Union Ave
Ste 202
Framingham, MA 01702Phone+1 508-665-6261Fax+1 508-665-4175
Education & Training
UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 2003 - 2006
Beth Israel Deaconess Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 2002 - 2003- UMass Chan Medical SchoolResidency, Internal Medicine, 1999 - 2002
Chicago Medical School/Rosalind Franklin University of Medicine ScienceInternship, Transitional Year, 1998 - 1999
Kakatiya Medical College NTRClass of 1995
Certifications & Licensure
MA State Medical License 2002 - 2025
FL State Medical License 2006 - 2010
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- A Trial of Chemo & Radiation Therapy for Pancreatic Cancer Start of enrollment: 2006 Jun 01
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
Publications & Presentations
PubMed
- 12 citationsCoordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination.Lacey J. McIntosh, Max P. Rosen, Kriti Mittal, Giles F. Whalen, Venu Bathini
Cancer Treatment Reviews. 2021-05-11 - 76 citationsCA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alon...E. G. Chiorean, D. D. Von Hoff, Michele Reni, Francis P. Arena, J. R. Infante
Annals of Oncology. 2016-04-01 - 3 citationsUtility of HNF-1B and a panel of lineage-specific biomarkers to optimize the diagnosis of pancreatic ductal adenocarcinoma.Shi Bai, James Lindberg, Giles F. Whalen, Venu Bathini, Jian Zou
American Journal of Cancer Research. 2021-01-01
Journal Articles
- Original Contribution Heterogeneous Mutational Profile and Prognosis Conferred by TP53 Mutations in Appendiceal Mucinous Neoplasms☆Ediz F Cosar, Mohammed Salhab, Otto Walter, Laura A Lambert, Carol Mathew, Xiaofei Wang, Venu Bathini, ScienceDirect
Press Mentions
University of Massachusetts Hematology Oncology FellowshipApril 30th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
